Doddareddy, Munikumar Reddy Choo, Hyunah Cho, Yong Seo Rhim, Hyewhon Koh, Hun Yeong Lee, Jung-Ha Jeong, Seong-Woo Pae, Ae Nim 2024-01-21T01:34:39Z 2024-01-21T01:34:39Z 2021-09-05 2007-01-15 0968-0896 https://pubs.kist.re.kr/handle/201004/134735 Virtual screening of the commercial databases was done by using a three dimensional pharmacophore previously developed for T-type calcium channel blockers using CATALYST (TM) program. Biological evaluation of 25 selected virtual hits resulted in the discovery of a highly potent compound VH04 with IC50 value of 0.10 mu M, eight times as potent as the known selective T-type calcium channel blocker, mibefradil. Search for similar compounds yielded several hits with micro-molar IC50 values and high T-type calcium channel selectivity. Based on the structure of the virtual hits, small molecule libraries with novel scaffolds were designed, synthesis and biological evaluation of which are currently in progress. This result shows a successful example of ligand based drug discovery of potent T-type calcium channel blockers. (c) 2006 Elsevier Ltd. All rights reserved. English PERGAMON-ELSEVIER SCIENCE LTD STABLE ANGINA MIBEFRADIL 3D pharmacophore based virtual screening of T-type calcium channel blockers Article 10.1016/j.bmc.2006.10.013 1 BIOORGANIC & MEDICINAL CHEMISTRY, v.15, no.2, pp.1091 - 1105 BIOORGANIC & MEDICINAL CHEMISTRY 15 2 1091 1105 scie scopus 000243315300047 2-s2.0-33845339664 Biochemistry & Molecular Biology Chemistry, Medicinal Chemistry, Organic Biochemistry & Molecular Biology Pharmacology & Pharmacy Chemistry Article STABLE ANGINA MIBEFRADIL virtual screening pharmacophore T-type calcium channel blockers